The firm's buyout group will acquire listed pharmaceutical company Par Pharmaceutical. TPG also has investments in several pharmaceutical companies through its TPG Biotech portfolio.
2 min read · 14 January 2013
The firm's buyout group will acquire listed pharmaceutical company Par Pharmaceutical. TPG also has investments in several pharmaceutical companies through its TPG Biotech portfolio.
2 min read · 14 January 2013
The firm's buyout group will acquire listed pharmaceutical company Par Pharmaceutical. TPG also has investments in several pharmaceutical companies through its TPG Biotech portfolio.
2 min read · 15 January 2013
Summit Partners is less than $33m away from a $350m target on its credit fund, which launched last year.
1 min read · 14 January 2013
Summit Partners is less than $33m away from a $350m target on its credit fund, which launched last year.
1 min read · 14 January 2013
Gatekeeper Altius Associates has held a first close for its second fund of funds on $50m after three months on the fundraising trail.
1 min read · 14 January 2013
The shortcomings in US infrastructure have received much attention. Jay Brown (pictured) and Robin Priest argue that a modest channeling of income tax revenue could be a big step towards addressing the problem
5 min read · 15 January 2013
The shortcomings in US infrastructure have received much attention. Jay Brown (pictured) and Robin Priest argue that a modest channeling of income tax revenue could be a big step towards addressing the problem
5 min read · 15 January 2013
The shortcomings in US infrastructure have received much attention. Jay Brown (pictured) and Robin Priest argue that a modest channeling of income tax revenue could be a big step towards addressing the problem
5 min read · 15 January 2013
Summit Partners is less than $33m away from a $350m target on its credit fund, which launched last year.
1 min read · 15 January 2013
